CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice. [electronic resource]
Producer: 20140325Description: 886-96 p. digitalISSN:- 1550-6606
- Age Factors
- Animals
- B-Lymphocytes -- immunology
- Chemokine CCL3 -- biosynthesis
- Chemokine CCL5 -- biosynthesis
- Chemotaxis, Leukocyte
- Disease Progression
- Drug Evaluation, Preclinical
- Humans
- Kidney -- immunology
- Ligands
- Lupus Nephritis -- immunology
- Mice
- Mice, Inbred NZB
- Myeloid Cells -- drug effects
- Neutrophil Infiltration -- drug effects
- RNA, Messenger -- biosynthesis
- Random Allocation
- Receptors, CCR1 -- antagonists & inhibitors
- Spleen -- immunology
- Splenomegaly -- etiology
- T-Lymphocyte Subsets -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.